Health & Nutrition

bg
Ozempic underworld: Inside the black market of obesity drugs

Ozempic underworld: Inside the black market of obesity...

A CNBC investigation into illegal weight loss drugs reveals a marketplace where...

bg
Apple could launch a ring to rival Samsung by 2026, research firm predicts

Apple could launch a ring to rival Samsung by 2026, research...

Apple could launch a connected ring to rival Samsung by 2026, according to CCS Insight,...

bg
Women's health startup Maven Clinic closes funding at $1.7 billion valuation

Women's health startup Maven Clinic closes funding at $1.7...

Maven Clinic closed a $125 million funding round at a $1.7 billion valuation, the...

bg
The Largest Study on Fasting in the World 

The Largest Study on Fasting in the World 

The Buchinger-modified fasting program is put to the test. A century ago, fasting—“starvation,...

bg
CVS is under pressure and considering a breakup. Here's why that could be risky

CVS is under pressure and considering a breakup. Here's...

A breakup would be a stunning reversal for CVS, which has spent tens of billions...

bg
Oura announces new smart ring with updated design and new sensors for $349

Oura announces new smart ring with updated design and new...

Oura announced the Oura Ring 4, which is available for preorder starting at $349.

bg
Can Fasting Be Healing? 

Can Fasting Be Healing? 

Where did the idea of therapeutic fasting come from? The story of life on Earth...

bg
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

Eli Lilly to build $4.5 billion research and manufacturing...

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments...

bg
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters

Healthy Returns: Pfizer pulls sickle cell disease drug...

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce...

bg
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment

Recursion gets FDA approval to begin phase 1 trials of...

Recursion said it was able to use its AI-enabled drug discovery platform to identify...